Susan London

News

Certain Antibodies Raise Rejection Risk in Heart Transplant Recipients

Author:: Susan London

Publish date: June 15, 2011

Major Finding: Patients who developed donor-specific antibodies or non–donor-specific antibodies in the first year were more likely to exper...

News

Certain Antibodies Raise Rejection Risk in Heart Transplant Recipients

Author:: Susan London

Publish date: June 15, 2011

Major Finding: Patients who developed donor-specific antibodies or non–donor-specific antibodies in the first year were more likely to exper...

News

ASCO: Melanoma Patients Respond to Combo BRAF, MEK Inhibitors

Author:: Susan London

Publish date: June 14, 2011

Major Finding: The objective response rate ranged from 50% to 77%, depending on doses, among patients who had not previously received any BRAF inh...

News

Melanoma Patients Respond to Combo of BRAF and MEK Inhibitors

Author:: Susan London

Publish date: June 14, 2011

Major Finding: The objective response rate ranged from 50% to 77%, depending on doses, among patients who had not previously received any BRAF inh...

News

Longer Imatinib Therapy Improves Outcomes For High-Risk GIST

Author:: Susan London

Publish date: June 6, 2011

Major Finding: Compared with their counterparts who were given imatinib for just 1 year after surgery, patients who were given imatinib for 3 year...

News

Longer Imatinib Therapy Improves Outcomes For High-Risk GIST

Author:: Susan London

Publish date: June 6, 2011

Major Finding: Compared with their counterparts who were given imatinib for just 1 year after surgery, patients who were given imatinib for 3 year...

News

Bevacizumab Shows Promise for High-Risk Ovarian Cancer

Author:: Susan London

Publish date: June 5, 2011

Major Finding: Relative to chemotherapy alone, chemotherapy plus bevacizumab was associated with a nonsignificant 15% reduction in the risk of dea...

News

Bevacizumab Shows Promise for High-Risk Ovarian Cancer

Author:: Susan London

Publish date: June 5, 2011

Major Finding: Relative to chemotherapy alone, chemotherapy plus bevacizumab was associated with a nonsignificant 15% reduction in the risk of dea...

News

Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer

Author:: Susan London

Publish date: June 5, 2011

Major Finding: Compared with patients assigned to chemotherapy plus placebo, patients assigned to chemotherapy plus bevacizumab had a 52% reductio...

News

Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer

Author:: Susan London

Publish date: June 5, 2011

Major Finding: Compared with patients assigned to chemotherapy plus placebo, patients assigned to chemotherapy plus bevacizumab had a 52% reductio...

News

COPD: Bacterial Infection Often Follows on Heels of Viral Infection

Author:: Susan London

Publish date: June 2, 2011

Major Finding: Fully 60% of COPD patients with rhinovirus infection also developed a bacterial infection, roughly a week later.Data Source: A stud...

News

COPD: Bacterial Infection Often Follows on Heels of Viral Infection

Author:: Susan London

Publish date: June 2, 2011

Major Finding: Fully 60% of COPD patients with rhinovirus infection also developed a bacterial infection, roughly a week later.Data Source: A stud...

News

COPD: Bacterial Infection Often Follows on Heels of Viral Infection

Author:: Susan London

Publish date: June 2, 2011

Major Finding: Fully 60% of COPD patients with rhinovirus infection also developed a bacterial infection, roughly a week later.Data Source: A stud...

News

LVH in Donor Does Not Raise Risk of Death

Author:: Susan London

Publish date: June 1, 2011

News

Men Receiving Women's Hearts Have Higher Mortality

Author:: Susan London

Publish date: June 1, 2011